
HALMA PLC UNSPON. ADR 2
Depository Receipt · US40637C3088 · A41CD3 (XFRA)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of HALMA PLC UNSPON. ADR 2
No Price
28.04.2026 20:00
Current Prices from HALMA PLC UNSPON. ADR 2
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
UTC |
HALMY
|
USD
|
28.04.2026 20:00
|
120,30 USD
| -1,11 USD
-0,91 %
|
Company Profile for HALMA PLC UNSPON. ADR 2 Depository Receipt
Halma plc, through its subsidiaries, provides technology solutions in the safety, health, and environmental markets. It operates through three segments: Safety, Environmental & Analysis, and Medical. The Safety segment provides fire detection, specialist fire suppression, elevator safety, security sensors, people and vehicle flow technologies, specialized interlocks that control critical processes safely, and explosion protection and corrosion monitoring systems. This segment serves elevator safety, fire suppression, people and vehicle flow, fire detection, pressure management, industrial access control, and safe storage and transfer markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; water, air and gases monitoring technologies; instruments that detect hazardous gases and analyses air quality; and systems for water analysis and treatment. It serves the optical analysis, water analysis and treatment, gas detection, and environmental monitoring markets. The Medical segment provides critical fluidic components used by medical diagnostics and original equipment manufacturers; laboratory devices and systems that provide information to understand patient health and enable providers to make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable positive outcomes across clinical specialties. This segment serves the life sciences, health assessment, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.
Company Data
Name HALMA PLC UNSPON. ADR 2
Company Halma plc
Website
https://www.halma.com
Primary Exchange
Frankfurt
Frankfurt
WKN A41CD3
ISIN US40637C3088
Asset Class Depository Receipt
Sector Industrials
Industry Conglomerates
CEO Marc Arthur Ronchetti
Market Capitalization 23 Mrd.
Country United Kingdom
Currency EUR
Employees 8,0 T
Address Misbourne Court, HP7 0DE Amersham
IPO Date 2019-10-22
Dividends from 'HALMA PLC UNSPON. ADR 2'
| Ex-Date | Dividend per Share |
|---|---|
| 19.12.2025 | 0,26 USD |
| 11.07.2025 | 0,38 USD |
| 20.12.2024 | 0,23 USD |
| 12.07.2024 | 0,33 USD |
| 21.12.2023 | 0,21 USD |
| 14.07.2023 | 0,31 USD |
| 22.12.2022 | 0,19 USD |
| 14.07.2022 | 0,28 USD |
| 11.02.2022 | 0,20 USD |
| 08.07.2021 | 0,26 USD |
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | HALMY |
| Frankfurt | H110.F |
More Shares
Investors who hold HALMA PLC UNSPON. ADR 2 also have the following shares in their portfolio:

